The effect of absolute configuration on activity, subtype selectivity (M3/M2) of 3α-acyloxy-6β-acetoxyltropane derivatives as muscarinic M3 receptor antagonists

被引:3
|
作者
Wang, Zhi-Peng [1 ]
Liu, Hui-Zhong [1 ]
Zhu, Liang [2 ]
Hu, You-Min [3 ]
Cui, Yong-Yao [2 ]
Niu, Yin-Yao [1 ]
Lu, Yang [1 ]
Chen, Hong-Zhuan [2 ]
机构
[1] Shanghai Jiao Tong Univ, Div Chem, Dept Pharm, Sch Med, Shanghai 200025, Peoples R China
[2] Shanghai Jiao Tong Univ, Div Pharmacol, Dept Pharm, Sch Med, Shanghai 200025, Peoples R China
[3] Shanghai Jiao Tong Univ, Funct Training Lab, Dept Pharm, Sch Med, Shanghai 200025, Peoples R China
关键词
Tropane derivative; 6S Configuration; Muscarinic antagonist; Enantiomer; Subtype selectivity; MUSCLE;
D O I
10.1016/j.bmc.2012.12.052
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Both enantiomers of 3 alpha-acyloxy-6 beta-acetoxyltropane derivatives 1-4 were prepared respectively and underwent functional studies and radioreceptor binding assays. 6S Enantiomers showed obvious muscarinic M3, M2 antagonistic activity, while the 6R ones elicited little muscarinic activity by functional studies. Besides, the affinity of 6S enantiomers to muscarinic M3 receptors of rat submandibulary gland, M2 receptors of rat left atria was much larger than that of corresponding 6R enantiomers. All these pharmalogical results indicated 6S configuration was favorable for 3 alpha-acyloxy-6 beta-acetoxyltropane derivatives to bind with muscarinic M3 or M2 receptors and elicited antagonistic activity. Furthermore, the muscarinic M3 activity and subtype selectivity (M3/M2) of 6S enantiomers could be improved by increasing the electron density of carbonyl oxygen or introducing methylene group between the carbonyl and phenyl ring in C-3 alpha position. Understanding the effect of absolute configuration on activity, subtype selectivity (M3/M2) of 3 alpha-acyloxy-6 beta-acetoxyltropane derivatives will provide the clues for designing muscarinic M3 antagonists with high activity and low side effects or toxicity. (C) 2013 Elsevier Ltd. All rights reserved.
引用
收藏
页码:1234 / 1239
页数:6
相关论文
共 50 条
  • [21] Muscarinic M3 receptor subtype gene expression in the human heart
    Hellgren, I
    Mustafa, A
    Riazi, M
    Suliman, I
    Sylvén, C
    Adem, A
    CELLULAR AND MOLECULAR LIFE SCIENCES, 2000, 57 (01) : 175 - 180
  • [22] DIFFERENTIAL-EFFECTS OF M2 AND M3 MUSCARINIC ANTAGONISTS ON THE SLEEP-WAKE CYCLE
    IMERI, L
    BIANCHI, S
    ANGELI, P
    MANCIA, M
    NEUROREPORT, 1991, 2 (07) : 383 - 385
  • [23] Mutation screening of the muscarinic M2 and M3 receptor genes in normal and asthmatic subjects
    Fenech, AG
    Ebejer, MJ
    Felice, AE
    Ellul-Micallef, R
    Hall, IP
    BRITISH JOURNAL OF PHARMACOLOGY, 2001, 133 (01) : 43 - 48
  • [24] The discovery of new spirocyclic muscarinic M3 antagonists
    Stocks, Michael J.
    Alcaraz, Lilian
    Bailey, Andrew
    Bowers, Keith
    Donald, David
    Edwards, Helen
    Hunt, Fraser
    Kindon, Nicholas
    Pairaudeau, Garry
    Theaker, Jill
    Warner, Daniel J.
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2010, 20 (24) : 7458 - 7461
  • [25] Synthesis and optimization of novel and selective muscarinic M3 receptor antagonists
    Kumar, Naresh
    Kaur, Kirandeep
    Aeron, Shelly
    Dharmarajan, Sankaranarayanan
    Silamkoti, Arun D. V.
    Mehta, Anita
    Gupta, Suman
    Chugh, Anita
    Gupta, Jang B.
    Salman, Mohammad
    Palle, Venkata P.
    Cliffe, Ian A.
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2007, 17 (18) : 5256 - 5260
  • [26] Discovery of long acting inhaled muscarinic M3 receptor antagonists
    Baettig, Urs
    Collingwood, Steve
    Janus, Diana
    Devereux, Nick
    Stanley, Emily
    Cox, Brian
    McCarthy, Clive
    Charlton, Steven
    Leighton-Davis, Juliette
    Fozard, John R.
    Baur, Francois
    Farr, Dave
    Mazzoni, Lazzaro
    Patel, Viral
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2007, 233 : 750 - 750
  • [27] Long-acting muscarinic M3 receptor antagonists -: GlaxoSmithKline
    Norman, Peter
    EXPERT OPINION ON THERAPEUTIC PATENTS, 2006, 16 (09) : 1315 - 1320
  • [28] Analogues of oxybutynin as M3 selective muscarinic receptor antagonists.
    Sarma, PKS
    Kumar, N
    Kaur, K
    Chugh, A
    Gupta, S
    Dutt, A
    Gupta, JB
    Mehta, A
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2004, 227 : U58 - U59
  • [29] Long-acting muscarinic M3 receptor antagonists -: Theravance
    Norman, Peter
    EXPERT OPINION ON THERAPEUTIC PATENTS, 2006, 16 (09) : 1321 - 1326
  • [30] Muscarinic M3 Receptor Blockage Inhibits The Development Of M2 Macrophages In Allergic Inflammation
    Jinno, M.
    Ohta, S.
    Tanaka, A.
    Satou, H.
    Uno, T.
    Fujiwara, A.
    Uchida, Y.
    Manabe, R.
    Kuwahara, N.
    Hirai, K.
    Miyata, Y.
    Yamaguchi, M.
    Homma, T.
    Yamamoto, M.
    Yokoe, T.
    Sagara, H.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2017, 195